MedTech News Briefs | August 14, 2023

Monday August 7th

New Brain Imaging Technique Developed in Austria. Live Information Optimized Nanoscopy Enabling Saturated Segmentation or LIONESS for short allows brain tissue to be viewed in high resolution 3D images. The new technique allows researchers to view live tissue in new depths.
Neuralink raises $280 million. Neuralink is a brain-computer interface makers and raised these funds as part of their Series D financing. The company is looking to develop a brain implant called N1.
Low cost 3D printed hand rehab device developed for low to middle income countries. Leading these projects is Wiliam Davidson Institue where they are dedicated to developing ways to help people in these countries. The new rehab device costs only $14.77 and weighs only 1.5 pounds.

Tuesday August 8th

MIT engineers develop sensor for early cancer detection. The sensor called CXCL12, mimics natural cell membrane function. The hope is that the device allows for at home testing with “high specificity and sensitivity.”
Research collaboration between PacBio, GeneDx and University of Washington. The collaboration is around studying “HiFi long-read whole genome sequencing.” The research allows for better diagnostic rates for pediatric patients with genetic conditions.
FDA investigational device exemption (IDE) granted to Orchestra BioMed. The IDE was granted for their balloon used for treating artery disease. The device, called Virtue SAB, delivers a formulation of the drug sirolimus into the patient.

Wednesday August 9th

Novel Imaging Technique visualizes Alzheimer causing protein. At the University of Geneva and Geneva University Hospital, the technique called tau PET helps to predict cognitive decline in patients better than normal imaging techniques. This allows for earlier detection and better treatment.
Development furthers on wireless ultrasound patch. The patch allows signals such as heart rate and blood pressure to be tracked. This marks a major step forward in at-home health care technology.
Hydrogel treatment developed for corneal disease. Developed by researchers at University of Ottawa, this treatment provides an alternative to cornea transplants. This allows treatment to those who don’t have corneal transplant as an option.

Thursday August 10th

AI-powered post surgical monitor released in Saudi Arabia and Canada. Called Stream Platform it was rolled out by FluidAI Medical. The platform leads to higher precision in diagnosing postoperative leaks and complications of digestive tract surgeries.
Cryoablation system received FDA approval. The device, POLARx Cryoablation System, was developed by Boston Scientic and receive approval on Thursday. The device is a minimally invasive procedure that freezes tissue near the pulmonary vein.
Research initiative started by Zeiss Microscopy to accelerate research. The initiative leads to the location having advance training and development of specialized microscopy workflows.

Friday August 11th

Ablation system developed by Boston Scientific poised for FDA approval. Farapulse, the pulsed-field ablation system, is expected to get approval next year. The system is used for cardiac ablation and can better assist treatment of atrial fibrillation or AFib.
510(k) Master File awarded to Anderson Sterilizers. This is a big win for companies that are trying to get away from ethylene oxide sterilization methods. This leads to the company not needing to resubmit for 510(k) clearance.
First Chinese patient dosed by Telix trial of Illuccix kit. The kit is designed to prepare for PET imaging of prostate cancer. The trial is being used as a bridge to receive FDA market authorization.

Want to see more highlights in medical device news from the week or see where you can find the full article? Check out the full post here:

ThinkMedTek